Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Assets (2018 - 2026)

Exagen filings provide 9 years of Current Assets readings, the most recent being $43.6 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 34.08% to $43.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $43.6 million, a 34.08% increase, with the full-year FY2025 number at $48.9 million, up 34.12% from a year prior.
  • Current Assets hit $43.6 million in Q1 2026 for Exagen, down from $48.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $103.6 million in Q1 2022 to a low of $32.5 million in Q1 2025.
  • Median Current Assets over the past 5 years was $48.9 million (2023), compared with a mean of $55.5 million.
  • Biggest five-year swings in Current Assets: crashed 41.85% in 2023 and later soared 47.9% in 2025.
  • Exagen's Current Assets stood at $72.6 million in 2022, then crashed by 34.11% to $47.8 million in 2023, then decreased by 23.8% to $36.5 million in 2024, then soared by 34.12% to $48.9 million in 2025, then dropped by 10.86% to $43.6 million in 2026.
  • The last three reported values for Current Assets were $43.6 million (Q1 2026), $48.9 million (Q4 2025), and $52.6 million (Q3 2025) per Business Quant data.